title: Leptin in early life: a key factor for the development of the adult metabolic profile.
abstract: Leptin levels during the perinatal period are important for the development of metabolic systems involved in energy homeostasis. In rodents, there is a postnatal leptin surge, with circulating leptin levels increasing around postnatal day (PND) 5 and peaking between PND 9 and PND 10. At this time circulating leptin acts as an important trophic factor for the development of hypothalamic circuits that control energy homeostasis and food seeking and reward behaviors. Blunting the postnatal leptin surge results in long-term leptin insensitivity and increased susceptibility to diet-induced obesity during adulthood. Pharmacologically increased leptin levels in the postnatal period also have long-term effects on metabolism. Nevertheless, this effect is controversial as postnatal hyperleptinemia is reported to both increase and decrease the predisposition to obesity in adulthood. The different effects reported in the literature could be explained by the different moments at which this hormone was administered, suggesting that modifications of the neonatal leptin surge at specific time points could selectively affect the development of central and peripheral systems that are undergoing modifications at this moment resulting in different metabolic and behavioral outcomes. In addition, maternal nutrition and the hormonal environment during pregnancy and lactation may also modulate the offspring's response to postnatal modifications in leptin levels. This review highlights the importance of leptin levels during the perinatal period in the development of metabolic systems that control energy homeostasis and how modifications of these levels may induce long-lasting and potentially irreversible effects on metabolism.
authors.affiliation: Department of Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Department of Pediatrics, Universidad Autónoma de Madrid and CIBER Fisiopatología de Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain. miriam.granado@uam.es
authors.forename: Miriam
authors.initials: M
authors.lastname: Granado
authors.forename: Esther
authors.initials: E
authors.lastname: Fuente-Martín
authors.forename: Cristina
authors.initials: C
authors.lastname: García-Cáceres
authors.forename: Jesús
authors.initials: J
authors.lastname: Argente
authors.forename: Julie A
authors.initials: JA
authors.lastname: Chowen
mesh_terms: D000818:Animals; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D007031:Hypothalamus; D007231:Infant, Newborn; D020738:Leptin / Q000097:blood* / Q000494:pharmacology; D039382:Maternal Nutritional Physiological Phenomena; D055442:Metabolome; D009765:Obesity / Q000209:etiology* / Q000378:metabolism; D011247:Pregnancy
chemical_list: D020738:Leptin